Rituximab is more effective than cyclophosphamide in the treatment of relapsing ANCA-associated vasculitis.Commentary on:NEJM 363-2010,221-232

Abstract

Cyclophosphamide is less effective than rituximab during the treatment of relapsing ANCA - associated vasculitis, risk of relaps, study RAVE, leukopenia, infection

Keywords

• Cyclophosphamide
• less effective than rituximab
• during the treatment of relapsing ANCA - associated vasculitis